1 week Ago By Defense World Staff
Stock analysts at StockNews.com began coverage on shares of OpGen ( NASDAQ:OPGN – Get Free Report ) in a research report issued on Saturday. The firm set a “sell” rating on the medical research company’s stock.
OpGen Price Performance Shares of NASDAQ:OPGN opened at $0.75 on Friday. The company’s 50-day moving average is $1.
33 and its 200 day moving average is $1.95. OpGen has a fifty-two week low of $0.
53 and a fifty-two week high of $9.90. About OpGen ( Get Free Report ) Featured Stories Five stocks we like better than OpGen What Does Downgrade Mean in Investing? Insiders Are Selling, But These 3 Stocks Are Must-Buys Learn Technical Analysis Skills to Master the Stock Market Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge What Investors Need to Know About Upcoming IPOs Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’ Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.
com's FREE daily email newsletter ..
